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RESEARCH ARTICLE Open Access
Whole-exome sequencing is a powerful
approach for establishing the etiological
diagnosis in patients with intellectual
disability and microcephaly
Patrick Rump1, Omid Jazayeri1, Krista K. van Dijk-Bos1, Lennart F. Johansson1,3, Anthonie J. van Essen1,
Johanna B. G. M. Verheij1, Hermine E. Veenstra-Knol1, Egbert J. W. Redeker2, Marcel M. A. M. Mannens2,
Morris A. Swertz3, Behrooz Z. Alizadeh4, Conny M. A. van Ravenswaaij-Arts1, Richard J. Sinke1
and Birgit Sikkema-Raddatz1*
Abstract
Background: Clinical and genetic heterogeneity in monogenetic disorders represents a major diagnostic challenge.
Although the presence of particular clinical features may aid in identifying a specific cause in some cases, the majority
of patients remain undiagnosed.
Here, we investigated the utility of whole-exome sequencing as a diagnostic approach for establishing a molecular
diagnosis in a highly heterogeneous group of patients with varied intellectual disability and microcephaly.
Methods: Whole-exome sequencing was performed in 38 patients, including three sib-pairs, in addition to or in
parallel with genetic analyses that were performed during the diagnostic work-up of the study participants.
Results: In ten out of these 35 families (29 %), we found mutations in genes already known to be related to a disorder
in which microcephaly is a main feature. Two unrelated patients had mutations in the ASPM gene. In seven other
patients we found mutations in RAB3GAP1, RNASEH2B, KIF11, ERCC8, CASK, DYRK1A and BRCA2. In one of the sib-pairs,
mutations were found in the RTTN gene. Mutations were present in seven out of our ten families with an established
etiological diagnosis with recessive inheritance.
Conclusions: We demonstrate that whole-exome sequencing is a powerful tool for the diagnostic evaluation of patients
with highly heterogeneous neurodevelopmental disorders such as intellectual disability with microcephaly. Our results
confirm that autosomal recessive disorders are highly prevalent among patients with microcephaly.
Keywords: Autosomal recessive inheritance, ASPM, BRCA2, CASK, DYRK1A, ERCC8, KIF11, Microcephaly, RAB3GAP1
RNASEH2B, RTTN, Whole-exome sequencing
Background
Microcephaly, a disproportionally small head size defined
as occipitofrontal circumference at or below −3 standard
deviations (SD), is an important neurological sign usually
associated with developmental delays and intellectual
disability [1]. Microcephaly can be congenital or may
develop later after birth. It can occur as a more or less
isolated finding or as one of the features of a more
complex syndrome. To date, according to the London
Medical Database [2], more than 800 syndromes with
microcephaly have been described, reflecting an enormous
number of possible diagnoses. Microcephaly may stem
from a wide variety of genetic or non-genetic conditions
and is considered to be a consequence of abnormal brain
development. Non-genetic causes include foetal alcohol
exposure, perinatal infections, asphyxia or haemorrhage.
Microcephaly can also occur in patients with inborn errors
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of metabolism, but this explains only a small proportion of
the total cases [3]. In the majority of patients a genetic
cause is suspected [4]. Chromosomal abnormalities may
account for 15–20 % of patients [5]. In a retrospective
study of 680 children with microcephaly [6], a specific
genetic cause was detected in 15.3 % of them, with numer-
ical chromosome aberrations accounting for 6.8 % and
microdeletions/duplications and monogenetic disorders
accounting for the other 8.5 %. Over the last few years the
number of genes related to microcephaly has been rising,
primarily as a result of the increased use of whole-exome
sequencing (for an overview see [7]). This clinical and
genetic heterogeneity represents a major diagnostic chal-
lenge. Although the presence of additional clinical findings
may aid in identifying a specific cause in some cases, the
majority of patients with microcephaly remain undiag-
nosed. Yet an early and specific diagnosis is important
because it can provide relevant information about
disease prognosis, appropriate medical or supportive
care, reproductive consequences for parents and other
family members, and prenatal diagnostic options. It may
also preclude unnecessary further, and possibly invasive,
diagnostic tests and evaluations.
The diagnostic work-up of microcephaly is extensive and
includes brain imaging, metabolic and ophthalmologic eval-
uations, skin or muscle biopsies, karyotyping or microarray
analysis, and mutation analyses of microcephaly genes.
However, the use of targeted approaches, such as candidate
gene testing by Sanger sequencing, is rather limited and
their diagnostic yield is generally low. In contrast, because
whole-exome sequencing does not require a priori know-
ledge of the gene or genes responsible for the disorder
under investigation [8], it has been proven to be a very
effective technique for identifying new genetic causes of
microcephaly [9, 10].
In this study, we investigated the utility of whole-exome
sequencing as a diagnostic approach for establishing a
molecular diagnosis in a highly heterogeneous group of
patients with microcephaly and intellectual disability.
Methods
Study subjects
We performed whole-exome sequencing in 38 patients,
including three sib-pairs, with severe microcephaly and
varied intellectual disabilities (Table 1). Patients were
recruited, both prospectively and retrospectively, from
the population of patients with intellectual disability
referred to the genetics departments of the University
Medical Centre Groningen and the Academic Medical
Centre in Amsterdam. Informed consent was obtained
from the participating families and the study protocol
was approved by the Ethics Committee of the University
Medial Centre Groningen.
The clinical characteristics of all 38 patients are summa-
rized in Table 1. The average age of the patients was
10 years (range 0 to 57 years). The majority (87 %) were
children, with only five patients over 18 years of age.
Severe microcephaly was defined as an occipital frontal
head circumference of at least 3 SDs below the age-related
mean according to Dutch national reference curves. The
mean occipital frontal head circumference Z-score for our
patients was −4.5 SD (range −3 to −8 SD). Consanguinity
was reported for the parents of six patients (patients# 16,
23, 27, 28, 29, 35), including one of the three sib-pairs.
Phenotype information was retrieved from medical
records and provided by the referring physicians.
All patients had undergone genetic testing during
their routine diagnostic work-up. In addition to whole-
exome sequencing, the work-up may have included
standard chromosome analysis, metabolic screening, or
DNA sequencing of individual or multiple genes. On aver-
age, 2.8 DNA tests (range 0 to 9 tests) were performed per
family (Additional file 1: Table S1). The most frequently
tested gene was ASPM. This gene was analysed in seven
(20 %) of the families.
Microarray analysis
SNP array analysis was performed in all patients prior
to inclusion using the IlluminaHumanCytoSNP-12 v2.1
DNA Analysis BeadChip following the manufacturer’s
instructions (Illumina, San Diego, CA, USA). Normalized
intensity and allelic ratios were analysed using GenomeS-
tudio Data Analysis Software and the cnvPartition v3.1.6
algorithm to assess copy number variation. No causal
copy number variants were found (data not shown).
Homozygosity was determined as were, if possible, any
shared haplotypes within a family. Shared homozygous
stretches between the siblings with consanguineous
parents were detected by selecting regions in which
both siblings shared the same homozygous alleles; for
the sib-pair with a recessive disorder we selected
regions in which they shared the same combination of
alleles, and for the sib-pair with a dominant disorder
we selected regions in which they shared at least one
allele at each SNP position. Stretches of homozygosity
were detected within a single patient by selecting
regions that only showed homozygous alleles.
Whole-exome sequencing
Library preparation was based on the SureSelect All Exon
V4 bait protocol (Agilent Technologies, Inc., Santa Clara,
CA, USA), and carried out on a PerkinElmer® SciClone
NGS workstation (PerkinElmer, Inc., Waltham, MA, USA).
Briefly, 3 micrograms of genomic DNA were randomly
fragmented with ultrasound using a Covaris® instrument
(Covaris, Inc., Woburn, MA, USA). Adapters were ligated
to both ends of the resulting fragments. Fragments with an
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Table 1 Characteristics of 38 patients with intellectual disability and microcephaly on whom whole-exome sequencing was performed
Patient Age Sex OFC (Z-score) Brain imaging (MRI) Additional clinical features
1 8 years f −3.0 Thin corpus callosum, mild enlarged
ventricles, hypoplasia of vermis and
cerebellum
Bilateral congenital cataracts, microphthalmia, pale optic discs,
hypogenitalism, axial hypotonia, hip dislocation, joint contractures,
severe intellectual disability
2 5 years f −5.3 Mild enlarged ventricles Intra-uterine growth retardation, neonatal hypoglycaemia,
sensineural deafness, moderate intellectual disability
3 3 years f −6.3 Simplified gyral pattern, thin corpus
callosum, wide peripheral liquor spaces
Feeding problems, recurrent respiratory infections, seizures,
severe developmental delay
4 2 years m −4.6 Normal Chorioretinopathy, mild developmental delay, hip dysplasia
(mother with microcephaly and learning problems)
5 8 years m −3.3 Normal Hypotelorism, cryptorchid testis, short stature, mild myopia,
hyperactivity, intellectual disability
6 31 year f −5.0 NA Mild intellectual disability, seizures, behavioural problems
(brother with intellectual disability and microcephaly)
7 4 years m −3.6 Thin corpus callosum, delayed myelinisation,
hypoplasia of frontal lobes
Strabismus, myoclonic jerks, spastic paraplegia, severe
developmental delay
8(a) 5 years f −4.4 Diffuse pachygyria Short stature, moderate intellectual disability, bilateral
metatarsus primus varus
9(a) 10 year f −5.2 Mild frontal lissencephaly, posterior frontal
pachygyria and parieto-occipital subcortical
band heterotopia
Short stature, Tetralogy of Fallot, embryotoxon posterior,
moderate intellectual disability (sister of patient 8)
10(b) 56 years f NA Normal CT-scan Severe microcephaly, chorioretinopathy, seizures, autism
spectrum disorder, severe intellectual disability
11(b) 57 years f −7.1 NA Chorioretinopathy, seizures, autism spectrum disorder, severe
intellectual disability (sister of patient 10)
12 3 years m −4.6 Temporal and parieto-occipital atrophy Cryptorchid testes, spasticity, feeding problems,
nephrocalcinosis, seizures, severe developmental delay
13 10 year m −5.0 Simplified gyral pattern, mild cerebellar
vermis hypoplasia
Hyperactivity, behavioural problems, speech delay, mild-moderate
intellectual disability
14 1 year m −3.2 Megacisterna magna, prominent sulci of
cerebellum
Brachycephaly, carp shaped mouth, uplifted ear lobes, mild
hypotonia, developmental delay
15 0.5 years f −7.0 Simplified gyral pattern, sub-cortical areas with
high signal intensity, prominent ventricles,
small cerebellum
Infantile spasms, hyperkinesia, hypertonia, feeding problems,
severe developmental delay
16 3 years m −3.3 Leucodystrophy, cerebral and cerebellar
atrophy
Short stature, truncal hypotonia, spasticity, contractures,
scoliosis, deafness, pigmentary retinopathy, mildly enlarged
liver and elevated aminotransferase, feeding problems,
cryptorchid testis, severe developmental delay, progressive
disease course (consanguineous parents)
17 2 years f −3.0 NA Short stature, embryotoxon posterior, feeding problems,
developmental delay
18 23 years m −3.0 Hypoplasia of cerebral and cerebellum
hemispheres, large cisterna magna,
abnormal myelinisation
Seizures, hypotonia, thoracic kyphosis, camptodactyly,
horseshoe kidney, small penis, auto mutilation, severe
intellectual disability
19 22 years f −4.0 Atrophy, mild enlarged ventricles on CT-scan Umbilical hernia, hip dysplasia, scoliosis, spasticity, feeding
problems, severe intellectual disability, seizures, no speech,
prominent upper incisors
20 4 years m −3.9 Normal Metopic ridge, pancreas annulare, unilateral cleft lip and palate,
short stature, severe developmental delay
21 11 year f −4.8 Hypoplasia frontal lobes, delay of myelinisation Chorioretinopathy, mild cortical cataracts
22 5 years f −8.0 Delayed myelinisation, thin corpus callosum Severe intellectual disability, hyperactivity disorder
23 2 years m −4.9 Wide peripheral liquor spaces Low birth weight, brachycephaly, hypertonia, severe
developmental delay (consanguineous parents)
24 19 years f −3.0 Focal temporal cortical dysplasia Postnatal growth retardation, obesity, seizures, primary
amenorrhea, hepatocellular carcinoma, mild-moderate intellectual
disability with regression
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average insert size of 220 bp were excised using the
LabChip XT® gel system (PerkinElmer) and amplified
by PCR (98o C 2 min; 11cycli of 98 °C 30s, 65 °C 30s,
72 °C 1 min; 72 °C 10 min). The quality of the product
was verified by capillary electrophoresis on the LabChip
GX instrument (PerkinElmer). Of this product, 500 ng
was subsequently hybridized to the Agilent SureSelect®
All Exon V4 bait pool (Agilent Technologies, Inc.).
During subsequent enrichment with PCR (98 °C 2 min;
11 cycli of 98 °C 30s, 57 °C 30s, 72 °C 1 min; 72 °C
10 min), individual samples were bar-coded and the
quality of the product was again verified on the LabChip
GX instrument. The product had an average fragment size
of 360 bp, and was sequenced using 100 base pair reads
paired-end on an Illumina® HiSeq2000 in pools of four
samples per lane (Illumina). Resulting image files were
processed including demultiplexing using standard
Illumina® base calling software.
All lanes of sequence data were aligned to the human
reference genome build b37, as released by the 1000
Genomes Project [11], using Burrows-Wheeler Aligner
[12]. Subsequently the duplicate reads were marked.
Using the Genome Analysis Toolkit (GATK) [13], re-
alignment around insertions and deletions detected in
the sequence data and in the 1000 Genomes Project
pilot [11] was performed, followed by base quality score
recalibration. During the full process the quality of the
data was assessed by performing Picard [14], GATK Cover-
age and custom scripts. SNP and indel discovery was done
using GATK Unified Genotyper and Pindel [15], respect-
ively, followed by annotation using SnpEff [16]. This pro-
duction pipeline was implemented using the MOLGENIS
compute [17] platform for job generation, execution and
monitoring. For each sample, a vcf file was generated that
included all variants. Mean target coverage of 64x was
achieved, with more than 82 % of targeted bases having at
Table 1 Characteristics of 38 patients with intellectual disability and microcephaly on whom whole-exome sequencing was performed
(Continued)
25 2 years m −4.5 Normal Short stature, adducted thumbs, hyperinsulinism,
hypothyroidism, feeding problems, developmental delay
26 5 years f −3.9 Multiple intra cerebral calcifications on CT-scan Feeding problems, short stature, seizures, spasticity, severe
developmental delay
27(c) 5 years m −4.5 Diffuse polymicrogyria Seizures, ventricle septum defect, feeding problems, spasticity,
severe developmental delay (consanguineous parents)
28(c) 13 years f NA Diffuse polymicrogyria Severe microcephaly, seizures, spasticity, severe intellectual
disability (sister of patient 27)
29 1 year f −3.0 Normal Feeding problems, recurrent ear infections, vesicoureteral
reflux, developmental delay (consanguineous parents)
30 1 year f −5.2 Simplified gyral pattern, hypoplasia of
frontal lobes and corpus callosum
Low birth weight, mild developmental delay
31 3 years m −3.4 Normal Microtia, iris and choroid coloboma, blepharophimosis,
hypertelorism, micropenis, short stature, ventricle septum
defect, inguinal hernia, feeding problems, developmental delay
(consanguineous parents)
32 14 years f −6.8 Simplified gyral pattern Seizures, behavioural problems, short stature, obesity, severe
intellectual disability
33 2 years f −3.1 Mild delay of myelinisation, wide liquor
spaces
Multicystic renal dysplasia, liver cysts and liver fibrosis, insulin-
dependent diabetes, sick thyroid syndrome, hypertension, mixed
hearing loss, developmental delay, mild complex III deficiency
34 0 year f −3.9 Abnormal gyration and myelinisation, small
cerebellum
Intra-uterine growth retardation, maternal oligohydramnios,
progressive renal failure (diffuse mesangial glomerulo sclerosis),
beaked nose, large floppy ears, long fingers
35 4 years m −4.4 Possible polymicrogyria Myopia, severe developmental delay
36 16 years f −3.7 Abnormal gyration parieto-temporal, hypoplasia
posterior part of corpus callosum
Short stature, behavioural problems, mild mental retardation
37 2 years m −3.5 Small brain, no other abnormalities Short stature, atrial septum defect, hypotonia, hypospadia,
blepharophymosis, ear tag, developmental delay
38 0.5 years m −5.2 Wide peripheral liquor spaces, abnormal
gyration fronto-parietal, small vermis, small
pons
Peripheral hypertonia, axial hypotonia, seizures, feeding
problems, developmental delay
(a), (b), (c) indicating the three sib-pairs
NA, not available
OFC, occipital frontal head circumference (expressed in standard deviations below the mean (Z-score) according
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least 20x coverage (Additional file 2: Table S2). Sample
swab was excluded by a concordance check with the SNP
information from the array.
Data interpretation
For data interpretation we uploaded the vcf files to
Cartagenia NGS bench (Cartagenia, Leuven, Belgium)
and then filtered the variants. We removed variants covered
by less than five sequence reads and possibly benign vari-
ants annotated in dbSNP133, the 1000 Genomes project,
the Seattle exome database [18], or the GoNL database [19]
with an allele frequency above 2 %. Additionally, variants
that were annotated in eight control samples, and for which
exome sequencing was performed in the same sequence
run, were also removed because they were considered to be
artefacts. The remaining variants were filtered on any
occurrence in known genes related to the phenotype, using
a filter with selected phenotype traits [HPO-terms for
microcephaly (HP:0011451, HP:0005484, HP:0000253),
abnormalities of the nervous system (HP:0002011,
HP:0000707), and abnormality of the head (HP:0000234)]
[20] in the Cartagenia filter tree. The remaining variants
were assumed to be related to the phenotype and further
filtered on an inheritance model. First, an autosomal reces-
sive inheritance model was applied for gene identification,
then an autosomal dominant or X-linked inheritance model
was applied. We considered variants resulting in transcrip-
tional or splice site effects as potentially pathogenic. For the
remaining group of variants, including those without a
phenotypic match, we checked for their presence in the
professional HGMD database (Biobase-international,
Beverly, MA, USA) and manually checked the rela-
tionships between variants and possible phenotypes.
The effect of potentially pathogenic variants was ex-
plored in the Alamut prediction program (Alamut,
Rouen, France) or based on information from available
databases and literature.
Validation of mutations by Sanger sequencing
Candidate pathogenic variants were validated by Sanger se-
quencing. When available, we studied segregation of these
confirmed variants by investigating DNA samples from
additional family members. Sequencing analysis was carried
out using flanking intronic primers (primer sequences are
available upon request). The forward primer was designed
with a PT1 tail (5′-TGTAAAACGACGGCCAGT-3′) and
the reverse primer with a PT2 tail (5′-CAGGAAACAGC
TATGACC-3′). PCR was performed in a total volume of
10 μl containing 5 μl AmpliTaq Gold ®Fast PCR Master
Mix (Applied Biosystems, Foster City, CA, USA), 1.5 μl
of each primer with a concentration of 0.5 pmol/μl
(Eurogentec, Serian, Belgium) and 2 μl genomic DNA
in a concentration of 40 ng/μl. Samples were PCR amplified
and sequenced according to our standard diagnostic proto-
cols (available upon request).
Causality criteria
To designate candidate pathogenic variants as causative,
variants confirmed by Sanger sequencing were required
to occur in genes in which mutations are known to
cause a disorder with clinical features consistent with
the patient’s phenotype. All variants were either reported
in the literature or HGMD database [21] to be deleterious,
classified as truncating or having a splice site effect, or pre-
dicted to be deleterious at least in three prediction algo-
rithms in Alamut. The presence of candidate pathogenic
variants was checked in the 1000 Genomes project, the
Seattle exome database [18], Exome Variant Server [22],
and Exome Aggregation Consortium (ExAC) [23]. Further-
more, when possible, familial segregation was investigated
to determine whether this was consistent with the expected
mode of inheritance. Causative variants were then reported
to the referring physicians.
Results
On average 34,580 single-nucleotide variants and small
insertions or deletions were found in each patient by
whole-exome sequencing (see Additional file 3: Table S3).
A molecular diagnosis could be established in 11 patients
from 10 families, corresponding to a diagnostic yield of
29 %. The inheritance of these mutations were autosomal
recessive (N = 7 families), autosomal dominant (N = 2) and
X-linked (N = 1). In three patients, a molecular diagnosis
was reached during their diagnostic work-up while
performing exome sequencing (patient 1, patient 26 and
patient 32). All three of these diagnoses were also reached
by whole-exome sequencing. In the remaining 25 families,
we identified five possibly candidate genes (data not shown).
However, for none of these candidates a causal relationship
to the phenotype of the patients could be proven.
Mutations were detected in nine different previously
identified microcephaly genes: ASPM, RAB3GAP1,
RNASEH2B, KIF11, RTTN, ERCC8, CASK, DYRK1A
and BRCA2 (Table 2). None of these mutations was
homo- or heterozygous present in the databases of benign
variants. One exception was the variant in RNASEH2B
[c.529G > A]. This mutation has been described before
[24] and is predicted to be pathogenic by Alamut . It was
heterozygous reported in the ExAC database with a fre-
quency of 0.13 %.
We identified ASPM mutations related to primary
microcephaly type 5 [25] in two independent families.
Patient 6 had two novel mutations in the ASPM gene: a
deletion of four base pairs resulting in a frameshift and a
splice site mutation. Sanger sequencing of the parents
confirmed segregation. The other ASPM mutations (in
patient 32) had already been detected by Sanger sequencing:
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Table 2 Established molecular diagnoses in patients with microcephaly using whole-exome sequencing
Patient Gene Transcript ID Transcript variants Protein variants Zygosity Related disorder Inheritance Reference for
mutations
1 RAB3GAP1 NM_012233.2 c.475_478delACTG p.T159Afs*19 Homozygous Warburg Micro syndrome 1[MIM 600118] AR Aligianis et al., [26]
4 KIF11 NM_004523.3 c.1040dupT p.S348Efs*8 Heterozygous Microcephaly with or without chorioretinopathy,
lymphedema, or mental retardation [MIM 152950]
AD Current study
6 ASPM NM_018136.4 c.7781_7784delAGAA
c.3168 + 1G > C
p. K2595Yfs*20 p.? Compound heterozygous Primary microcephaly 5 [MIM 608716] AR Current study
8&9 RTTN NM_173630.3 c.4186delC c.2594A > G p.E1397Kfs*7 p.H865R Compound heterozygous Polymicrogyria with seizures [MIM 614833] AR Current study
16 ERCC8 NM_000082.3 c.295_297delinsTG p.R99Sfs*26 Homozygous Cockayne syndrome type A [MIM 216400] AR Current study
19 CASK NM_003688.3 c.2302 + 2 T > G p.? Heterozygous Mental retardation and microcephaly with
pontine and cerebellar hypoplasia
[MIM 300749]
XL Current study
23 DYRK1A NM_001396.3 c.1433delT p.F478Sfs*114 Heterozygous Autosomal dominant mental retardation 7
[MIM 614104]
AD Current study
24 BRCA2 NM_000059.3 c.9672dupA p.Tyr3225Ilefs*30 Homozygous Fanconi anemia, complementation group D1
[MIM 605724]
AR Tea et al., [42]
26 RNASEH2B NM_024570.3 c.529G > A c.554 T > G p.A177T p.V185G Compound heterozygous Aicardi-Goutières syndrome 2[MIM 610181] AR Crow et al., [24]
32 ASPM NM_018136.4 c.2389C > T c.2053dupA p.R797* p.N688Kfs*5 Compound heterozygous Primary microcephaly 5 [MIM 608716] AR Passemard et al., [25]
Current study
AR Autosomal recessive, AD Autosomal dominant, XL X-linked, MIM Mendelian inheritance in man number (http://omim.org)















a stop mutation and an insertion of one base pair resulting
in a frameshift.
In two patients with clinically recognizable syndromes
(i.e. Warburg Micro syndrome and Aicardi-Goutières
syndrome), mutations in RAB3GAP1 (patient 1) [26] and
RNASEH2B (patient 26) [24] related to these conditions
were identified during their diagnostic work-up as well as
by whole-exome sequencing. In RAP3GAP1 a homozy-
gous deletion of four base pairs in exon 6 was detected.
This deletion creates a frameshift starting at codon
Thr159. The new reading frame ends in a stop codon 18
positions downstream.
A frame-shift mutation in the KIF11 gene was identified
in patient 4, who was known to have microcephaly and ret-
inopathy, consistent with the phenotype. The mutation is
an insertion of one base pair resulting in a frameshift and
after eight amino acids causing a stop codon. The mutation
in this patient proved to be inherited from the mother,
who also had microcephaly and mild learning problems,
but who was not found to have any ophthalmologic abnor-
malities. The unaffected maternal aunt of patient 4 did not
carry the mutation.
We found a compound heterozygous frame-shift and
missense mutation in the RTTN gene encoding the
centrosome-associated protein Rotatin in one of the three
sib-pairs (patients 8 and 9). The missense mutation was
predicted as deleterious by several programs (including
Polyphen, SIFT, and Mutation taster).
In the ERCC8 gene a homozygous frame-shift mutation
was found in patient 16, located in an 8 Mb homozygous
region causing a stop codon further in the exon. Sanger
sequencing of the parents confirmed that both were
carriers of this heterozygous mutation.
We further found a splice-site mutation in the CASK
gene in patient 19, and analysis of the parents confirmed
that this was a de novo mutation. This mutation results
in a predicted change of the splice site.
We identified a frame-shift mutation in the DYRK1A
gene in patient 23, which was not inherited from the
patient’s mother. Because DNA of the patient’s father
was not available for testing, we were unable to confirm
a de novo event in our patient, but the mutation is highly
likely to be pathogenic.
A homozygous mutation in the BRCA2 gene was
detected in patient 24. Biallelic BRCA2 mutations cause
Fanconi anaemia complementation group D1 [27], a
phenotype consistent with the phenotype of this patient.
Sanger sequencing of the parents confirmed segregation.
Since both parents of our patient were heterozygous for
the mutation, and because of the associated increased
risk for cancer, both of their families were offered appro-
priate genetic counselling and mutation screening. To
date, no other family members have been reported to
have cancer.
Discussion
Overall, a molecular diagnosis was established in 29 % of
the families with microcephaly studied using whole-exome
sequencing. This diagnostic yield is comparable to the
diagnostic yield of 25 % for whole-genome sequencing
reported in a study of patients with a wide range of
suspected genetic disorders, mostly related to neurologic
conditions [28]. Our results are also in line with other
studies on the diagnostic utility of whole-exome sequen-
cing in genetically highly heterogeneous disorders. Whole-
exome sequencing had a higher diagnostic yield than
Sanger sequencing in patients with deafness (44 % vs.
10 %), blindness (52 % vs. 25 %), mitochondrial diseases
(16 % vs. 11 %) and movement disorders (20 % vs. 5 %)
[29]. In a study of 188 probands from families with con-
sanguineous parents and two or more affected children,
mutations in known genes were found in 27 % of the
patients [8]. A similar diagnostic yield of approximately
25 % was obtained in a study on consanguineous
families from Qatar [30].
We found mutations that are highly likely to be
causative in nine different genes known to be associ-
ated with a disorder in which microcephaly is an im-
portant phenotypic feature. The ASPM gene is related
to primary microcephaly type 5, which is the most
common cause of autosomal recessive inherited pri-
mary microcephaly [31]. Although ASPM was the most
frequently tested gene during the diagnostic work-up
of the patients (Additional file 1: Table S1), in one of
these two families this gene had not been tested. Muta-
tions in the KIF11 gene are known to cause autosomal
dominant inherited microcephaly with or without
chorioretinopathy, lymphedema, or mental retardation
[32], a phenotype that is consistent with the clinical
features of the patient in which we identified a KIF11
mutation. Homozygous missense mutations in the
RTTN gene have recently been identified in patients
with microcephaly, intellectual disability, epilepsy and
bilateral polymicrogyria [33]. The p. H865R mutation
identified in our family results in a substitution of an
amino acid that is located in the second Armadillo-like
domain of Rotatin, a protein-protein interacting
domain that is highly conserved among species. Sanger
sequencing in both parents and two unaffected siblings
confirmed that the mutations segregated with the clin-
ical phenotype in this family, further proving causality.
In our patients, the type of cortical malformations
differed and the degree of microcephaly was more
severe than in these published cases. It is known that
such heterogeneity in distribution, severity and type of
cortical malformations can occur in relation to muta-
tions in one specific gene, as has been observed with
mutations in the GPR56 gene [33, 34]. ERCC8 gene
mutations cause Cockayne syndrome type A [35].
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Although, in retrospect, this diagnosis is consistent
with the clinical features of our patient, it had not been
considered prior to our discovery of the ERCC8 gene
mutation by whole-exome sequencing. When the
patient was re-evaluated, his facial features had chan-
ged substantially and had become more characteristic
of Cockayne syndrome. Mutations in the CASK gene
cause mental retardation with microcephaly and pon-
tocerebellar hypoplasia [36]. This X-linked condition is
seen more frequently in females than in males [37].
The presence of severe intellectual disability, spasticity,
seizures, absence of speech, and prominent upper inci-
sors reported in our CASK patient are known clinical
features associated with this disorder [38]. Unfortu-
nately, no brain MRI was available from this patient so
it remains unknown whether she also had pontine or
cerebellar hypoplasia. The absence of this information
may also explain why this diagnosis had not been con-
sidered prior to whole-exome sequencing. DYRK1A
mutations cause autosomal dominant mental retard-
ation type 7, in which microcephaly is an important
clinical finding [39, 40]. Typically, de novo DYRK1A
mutations are found [39] as was most likely the case in
our patient. Biallelic BRCA2 mutations are known to
cause Fanconi anaemia type D1 [41], and we found a
homozygous mutation in this gene. Secondary micro-
cephaly and hepatocellular carcinoma, as seen in our
patient, are known features of Fanconi anaemia [27].
This particular BRCA2 mutation has been identified in
families with familial breast cancer [42].
In our cohort an autosomal recessive disorder was
detected in 7/10 of the families with an established diag-
nosis, while only eight out of 35 (23 %) families had been
suspected of having a recessive disorder (six consanguin-
eous families and two families with affected siblings).
This is consistent with the high empirical recurrence risk
in sibs (approximately 15-20 %) of patients with severe
primary microcephaly without an identified cause [43].
Our results suggest that autosomal recessive inheritance
is far more frequent in patients with microcephaly than
in patients with intellectual disability overall [28, 44]. In
a study of 100 patients with severe intellectual disability,
mostly de novo mutations with an assumed dominant
effect were identified and only one patient was found to
have an autosomal recessive disorder [45].
Our results confirm the clinical and genetic hetero-
geneity in patients with microcephaly. When whole-
exome sequencing is performed early in the diagnostic
work-up of patients, it may prevent other, unneces-
sary, diagnostic evaluations. Most of the patients in
our study had had extensive diagnostic evaluations but
these had not led to a specific diagnosis in the major-
ity of cases. Neveling et al. calculated that when three
or more genes per patient are investigated by Sanger
sequencing, whole-exome sequencing is more cost
effective and has a higher diagnostic yield [29].
Conclusions
Our results demonstrate that whole-exome sequencing is a
powerful tool for the diagnostic evaluation of highly hetero-
geneous neurodevelopmental disorders. We performed
whole-exome sequencing in 35 families with intellectual
disability and microcephaly. A molecular diagnosis could
be established in 29 % of the studied families. In 70 %
of the families an autosomal recessive condition was
present, confirming that this inheritance mode is more
prevalent among patients with intellectual disability
who have microcephaly.
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